Literature DB >> 22777057

Lung cancer: locally advanced NCSLC in the elderly: which treatment?

Cesare Gridelli.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22777057     DOI： 10.1038/nrclinonc.2012.112

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

Authors:  Shinji Atagi; Masaaki Kawahara; Akira Yokoyama; Hiroaki Okamoto; Nobuyuki Yamamoto; Yuichiro Ohe; Toshiyuki Sawa; Satoshi Ishikura; Taro Shibata; Haruhiko Fukuda; Nagahiro Saijo; Tomohide Tamura
Journal:  Lancet Oncol       Date:  2012-05-22       Impact factor: 41.316

2.  The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

Authors:  B Movsas; C Scott; W Sause; R Byhardt; R Komaki; J Cox; D Johnson; C Lawton; A R Dar; T Wasserman; M Roach; J S Lee; E Andras
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-12-01       Impact factor: 7.038

Review 3.  Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Authors:  Anne Aupérin; Cecile Le Péchoux; Estelle Rolland; Walter J Curran; Kiyoyuki Furuse; Pierre Fournel; Jose Belderbos; Gerald Clamon; Hakki Cuneyt Ulutin; Rebecca Paulus; Takeharu Yamanaka; Marie-Cecile Bozonnat; Apollonia Uitterhoeve; Xiaofei Wang; Lesley Stewart; Rodrigo Arriagada; Sarah Burdett; Jean-Pierre Pignon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

4.  Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.

Authors:  A Aupérin; C Le Péchoux; J P Pignon; C Koning; B Jeremic; G Clamon; L Einhorn; D Ball; M G Trovo; H J M Groen; J A Bonner; T Le Chevalier; R Arriagada
Journal:  Ann Oncol       Date:  2006-03       Impact factor: 32.976

5.  Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812).

Authors:  Shinji Atagi; Masaaki Kawahara; Tomohide Tamura; Kazumasa Noda; Koshiro Watanabe; Akira Yokoyama; Takahiko Sugiura; Hiroshi Senba; Satoshi Ishikura; Hiroshi Ikeda; Naoki Ishizuka; Nagahiro Saijo
Journal:  Jpn J Clin Oncol       Date:  2005-04       Impact factor: 3.019

6.  Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

Authors:  M Werner-Wasik; C Scott; J D Cox; W T Sause; R W Byhardt; S Asbell; A Russell; R Komaki; J S Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

7.  The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

Authors:  Steven E Schild; Philip J Stella; Susan M Geyer; James A Bonner; William L McGinnis; James A Mailliard; Jeffery Brindle; Aminah Jatoi; James R Jett
Journal:  J Clin Oncol       Date:  2003-07-21       Impact factor: 44.544
  7 in total
  1 in total

1.  Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients.

Authors:  Ying Gao; Fei Gao; Jin-Lu Ma; Xiao-Zhi Zhang; Yi Li; Li-Ping Song; Dong-Li Zhao
Journal:  Patient Prefer Adherence       Date:  2015-08-19       Impact factor: 2.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.